Elevated DKK1 expression: a promising prognostic biomarker and therapeutic target in head and neck squamous cell carcinoma

被引：0
|
作者：
Jerjes, Waseem [1 ,2 ]
机构：
[1] Hammersmith & Fulham PCN, Res & Dev Unit, London, England
[2] Imperial Coll London, Fac Med, London, England
来源：
EXPERT REVIEW OF ANTICANCER THERAPY | 2024年 / 24卷 / 09期
关键词：
Dickkopf-1 (DKK1); head and neck squamous cell carcinoma (HNSCC); prognostic biomarker; radiotherapy resistance; personalized treatment;
D O I：
10.1080/14737140.2024.2379920
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：917 / 919
页数：3
相关论文
共 50 条
  • [1] Elevated DKK1 expression is an independent unfavorable prognostic indicator of survival in head and neck squamous cell carcinoma
    Gao, Haihe
    Li, Lisha
    Xiao, Mang
    Guo, Yongwei
    Shen, Yi
    Cheng, Lixin
    Tang, Ming
    CANCER MANAGEMENT AND RESEARCH, 2018, 10 : 5083 - 5089
  • [2] HtrA3: a promising prognostic biomarker and therapeutic target for head and neck squamous cell carcinoma
    Chen, Yan
    Yang, Jianfeng
    Jin, Hangbin
    Wen, Weiwei
    Xu, Ying
    Zhang, Xiaofeng
    Wang, Yu
    PEERJ, 2023, 11
  • [3] HtrA3: a promising prognostic biomarker and therapeutic target for head and neck squamous cell carcinoma
    Chen, Yan
    Yang, Jianfeng
    Jin, Hangbin
    Wen, Weiwei
    Xu, Ying
    Zhang, Xiaofeng
    Wang, Yu
    PEERJ, 2023, 11
  • [4] The role of SPP1 as a prognostic biomarker and therapeutic target in head and neck squamous cell carcinoma
    Cai, X.
    Zhang, H.
    Li, T.
    INTERNATIONAL JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY, 2022, 51 (06) : 732 - 741
  • [5] FGFR1 Is a Potential Prognostic Biomarker and Therapeutic Target in Head and Neck Squamous Cell Carcinoma
    Koole, Koos
    Brunen, Diede
    van Kempen, Pauline M. W.
    Noorlag, Rob
    de Bree, Remco
    Lieftink, Cor
    van Es, Robert J. J.
    Bernards, Rene
    Willems, Stefan M.
    CLINICAL CANCER RESEARCH, 2016, 22 (15) : 3884 - 3893
  • [6] FGFR1 as a prognostic biomarker and potential therapeutic target in head and neck squamous cell carcinoma.
    Willems, Stefan M.
    Koole, Koos
    Brunen, Diede
    van Kempen, Pauline Md
    Noorlag, Rob
    Bijlsma, Rhode
    van Es, RobertJ. J.
    Lieftink, Cor
    de Bree, Remco
    Bernards, Rene
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [7] FGFR1 is a potential prognostic biomarker and therapeutic target in head and neck Squamous Cell Carcinoma (SCC)
    Koole, K.
    Brunen, D.
    van Kempen, P.
    Noorlag, R.
    de Bree, R.
    Lieftink, C.
    van Es, R.
    Bernards, R.
    Willems, S.
    VIRCHOWS ARCHIV, 2016, 469 : S31 - S31
  • [8] DKK1 is a potential target for enhancing the efficiency of radioimmunotherapy in head and neck squamous carcinoma.
    Ye, Xinyu
    Jian, Zhang
    Lu, Yi
    Gong, Yingxuan
    Jiang, Xinyu
    Li, Yueming
    Wang, Yinghao
    Li, Xiuzhi
    Liu, Jingwen
    Quan, Rencui
    CANCER RESEARCH, 2022, 82 (12)
  • [9] Elevated RUNX1 is a prognostic biomarker for human head and neck squamous cell carcinoma
    Feng, Xiaodong
    Zheng, Zhiwei
    Wang, Yi
    Song, Guanghui
    Wang, Lu
    Zhang, Zhijun
    Zhao, Jinxia
    Wang, Qing
    Lun, Limin
    EXPERIMENTAL BIOLOGY AND MEDICINE, 2021, 246 (05) : 538 - 546
  • [10] Role of prognostic gene DKK1 in oral squamous cell carcinoma
    Liu, Yujiao
    Wei, Congcong
    Wang, Song
    Ding, Shuxin
    Li, Yanan
    Li, Yongguo
    Zhang, Dongping
    Zhu, Guoxiong
    Meng, Zhen
    ONCOLOGY LETTERS, 2024, 27 (02)
12345